AEON BioPharma, Inc.

10:30 AM - 10:45 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
An emerging, global biopharma company established to independently pursue the rapidly growing, multi-billion-dollar therapeutic toxin market.
Company Type:
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
ABP-450 (prabotulinumtoxinA.xvfs)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):